Cancer vaccination at older age

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by various age-related changes of the immune system, such as lack of naïve T cells, defects in activation pathways of T cells and antigen-presenting cells, and age-related changes in the tumor microenvironment. Natural killer, natural killer T cells, and γδT cells of the innate immune system also change with age but these responses may be more susceptible for improvement than adaptive immune responses at older age. This chapter compares various studies involving adaptive and innate immune responses in elderly and cancer patients, as well as cancer vaccination at young and old age. Finally, potential new directions in cancer vaccination at older age are discussed.

Original languageEnglish (US)
Title of host publicationCancer and Aging: From Bench to Clinics
PublisherS. Karger AG
Pages28-37
Number of pages10
Volume38
ISBN (Print)9783318023077, 9783318023060
DOIs
StatePublished - Jan 18 2013

Fingerprint

Vaccination
T-Lymphocytes
Adaptive Immunity
Immune System
Neoplasms
Natural Killer T-Cells
Tumor Microenvironment
Viral Tumor Antigens
Antigen-Presenting Cells
Innate Immunity

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Gravekamp, C. (2013). Cancer vaccination at older age. In Cancer and Aging: From Bench to Clinics (Vol. 38, pp. 28-37). S. Karger AG. https://doi.org/10.1159/000343596

Cancer vaccination at older age. / Gravekamp, Claudia.

Cancer and Aging: From Bench to Clinics. Vol. 38 S. Karger AG, 2013. p. 28-37.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gravekamp, C 2013, Cancer vaccination at older age. in Cancer and Aging: From Bench to Clinics. vol. 38, S. Karger AG, pp. 28-37. https://doi.org/10.1159/000343596
Gravekamp C. Cancer vaccination at older age. In Cancer and Aging: From Bench to Clinics. Vol. 38. S. Karger AG. 2013. p. 28-37 https://doi.org/10.1159/000343596
Gravekamp, Claudia. / Cancer vaccination at older age. Cancer and Aging: From Bench to Clinics. Vol. 38 S. Karger AG, 2013. pp. 28-37
@inbook{2039784c8b0d47219d5d100c2a28c13a,
title = "Cancer vaccination at older age",
abstract = "Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by various age-related changes of the immune system, such as lack of na{\"i}ve T cells, defects in activation pathways of T cells and antigen-presenting cells, and age-related changes in the tumor microenvironment. Natural killer, natural killer T cells, and γδT cells of the innate immune system also change with age but these responses may be more susceptible for improvement than adaptive immune responses at older age. This chapter compares various studies involving adaptive and innate immune responses in elderly and cancer patients, as well as cancer vaccination at young and old age. Finally, potential new directions in cancer vaccination at older age are discussed.",
author = "Claudia Gravekamp",
year = "2013",
month = "1",
day = "18",
doi = "10.1159/000343596",
language = "English (US)",
isbn = "9783318023077",
volume = "38",
pages = "28--37",
booktitle = "Cancer and Aging: From Bench to Clinics",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Cancer vaccination at older age

AU - Gravekamp, Claudia

PY - 2013/1/18

Y1 - 2013/1/18

N2 - Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by various age-related changes of the immune system, such as lack of naïve T cells, defects in activation pathways of T cells and antigen-presenting cells, and age-related changes in the tumor microenvironment. Natural killer, natural killer T cells, and γδT cells of the innate immune system also change with age but these responses may be more susceptible for improvement than adaptive immune responses at older age. This chapter compares various studies involving adaptive and innate immune responses in elderly and cancer patients, as well as cancer vaccination at young and old age. Finally, potential new directions in cancer vaccination at older age are discussed.

AB - Cancer vaccination is less effective at old than at young age, due to T cell unresponsiveness. This is caused by various age-related changes of the immune system, such as lack of naïve T cells, defects in activation pathways of T cells and antigen-presenting cells, and age-related changes in the tumor microenvironment. Natural killer, natural killer T cells, and γδT cells of the innate immune system also change with age but these responses may be more susceptible for improvement than adaptive immune responses at older age. This chapter compares various studies involving adaptive and innate immune responses in elderly and cancer patients, as well as cancer vaccination at young and old age. Finally, potential new directions in cancer vaccination at older age are discussed.

UR - http://www.scopus.com/inward/record.url?scp=84925759405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925759405&partnerID=8YFLogxK

U2 - 10.1159/000343596

DO - 10.1159/000343596

M3 - Chapter

C2 - 23503513

SN - 9783318023077

SN - 9783318023060

VL - 38

SP - 28

EP - 37

BT - Cancer and Aging: From Bench to Clinics

PB - S. Karger AG

ER -